Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • Guaranteed Paid Placement
  • SocialBoost
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • SocialBoost
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Milestone Achievements for Seeds and Traits and Improved Performance Across Core Business Drive Stronger Outlook for Monsanto

Company Raises Full-Year Ongoing Earnings Per Share Guidance to $2.84 to $2.88, or $2.82 to $2.86 As-Reported, While Increasing Free Cash Flow Guidance for the Second Time


News provided by

Monsanto Company

Jun 29, 2011, 08:00 ET

Share this article

Share toX

Share this article

Share toX

ST. LOUIS, June 29, 2011 /PRNewswire/ -- Looking at the scorecard of milestones to achieve this year, Monsanto Company (NYSE: MON) executives today said the strength of its seeds and traits business in the United States and Latin America combined with the well-received implementation of its agricultural productivity strategy drove a successful fiscal third quarter for the company.  The key third quarter – one of the company's most significant historically – is a highlight in a year that has created real momentum with the establishment of key products in the United States, accelerated adoption in Latin America and the growth of other key markets.  The company is well-positioned to conclude fiscal 2011 at a high-teens ongoing earnings growth target and translate that growth into greater free cash flow.





Third Quarter



Nine Months

($ in millions)

2011


2010


2011


2010

Net Sales By Segment













Corn seed and traits

$

1,123


$

1,020


$

4,134


$

3,836


Soybean seed and traits


605



549



1,446



1,383


Cotton seeds and traits


487



420



666



513


Vegetable seeds


216



204



628



600


All other crops seeds and traits


216



169



357



309

TOTAL Seeds and Genomics

$

2,647


$

2,362


$

7,231


$

6,641















Agricultural productivity

$

943


$

600


$

2,318


$

1,908

TOTAL Agricultural Productivity

$

943


$

600


$

2,318


$

1,908














TOTAL Net Sales

$

3,590


$

2,962


$

9,549


$

8,549














Gross Profit

$

1,955


$

1,387


$

5,081


$

4,225














Operating Expenses

$

952


$

828


$

2,535


$

2,426














Interest Expense – Net

$

18


$

17


$

66


$

72

Other Expense (Income) – Net

$

15


$

7


$

38


$

(3)














Net Income Attributable to Monsanto Company

$

680


$

384


$

1,703


$

1,252














Diluted Earnings per Share (See note 1.)

$

1.26


$

0.70


$

3.14


$

2.27

Items Affecting Comparability – EPS Impact













Restructuring charges


—



0.11



0.01



0.23


Income on discontinued operations


—



—



(0.01)



(0.01)

Diluted Earnings per Share from Ongoing Business (For the definition of ongoing EPS, see note 1.)

$

1.26


$

0.81


$

3.14


$

2.49














Effective Tax Rate


28%



26%



29%



27%






Third Quarter

Nine Months

Comparison as a Percent of Net Sales:

2011


2010

2011


2010


Gross profit

54

%


47

%

53

%


49

%


Selling, general and administrative expenses (SG&A)

16

%


17

%

16

%


18

%


Research and development expenses

10

%


10

%

10

%


10

%


Income from continuing operations before income taxes

27

%


18

%

26

%


20

%


Net income attributable to Monsanto Company

19

%


13

%

18

%


15

%


"The third quarter is always an important quarter for Monsanto, as it effectively concludes our fiscal year from an operational standpoint," said Hugh Grant, Monsanto's president and chief executive officer.  "Our U.S. selling season is almost complete, and farmers in Latin America are now harvesting their crops.  That gives us real data to validate the momentum we've felt.  We made significant changes to our business this year, and those changes resonated with our customers.  We earned their business and achieved what we set out to achieve: unit volume growth in our core crops, a successful implementation of our agricultural productivity strategy and sustained cost-discipline across our operations.  That positions us well for the coming years and the mid-teens earnings growth opportunity we see for this company."

Results of Operations

Net sales increased $628 million, or 21 percent, in the three-month comparison driven by unit volume growth in both the seeds and genomics and agricultural productivity segments.  Net income attributable to Monsanto Company in the third quarter was $680 million.

Gross profit rose 41 percent in the quarter to approximately $2 billion, with margins higher due to mix and cost improvements.  For the first nine months, gross profit is up 20 percent or $856 million.

Operating expenses were up $124 million in the third quarter compared to the prior year, as expected. In the three-month comparison, selling, general and administrative (SG&A) expenses were up 20 percent, tracking with the increase expected as the company realizes more investments in employee and sales incentives and new product launches.  Research & Development (R&D) expenses increased as the company continues to make incremental investments in R&D to help fuel future growth.

Earnings per share (EPS) for the third quarter were $1.26 on both an as-reported basis and an ongoing basis. EPS for the first nine months of fiscal year 2011 were $3.14 on both an as-reported basis and an ongoing basis. (For a reconciliation of EPS to ongoing EPS see page 1).

Cash Flow

The company's strong cash position continued in the third quarter.  For the first nine months of the fiscal year, cash flow from operations was a source of $944 million compared with a use of $538 million in the first nine months last year. Net cash required by investing activities for the first nine months of fiscal year 2011 was $707 million, compared to $614 million for the same period of fiscal year 2010.  

Net cash required by financing activities for the first nine months of 2011 was $766 million, compared to net cash required of $323 million for the same period of fiscal year 2010.  

Free cash flow was a source of $237 million for the first nine months of fiscal year 2011, compared to a use of nearly $1.2 billion for the first nine months of fiscal year 2010. (For a reconciliation of free cash flow, see note 1.)

The company continues to make progress on its current $1 billion, three-year share repurchase authorization, representing one of its most significant uses of cash.  The company spent $105 million on repurchases in the third quarter for total repurchases to date of $487 million, nearly half the authorization.

Outlook

The company raised its full-year as-reported and ongoing EPS guidance and free cash flow guidance.  The company expects full-year 2011 ongoing EPS in the range of $2.84 to $2.88.  Full-year 2011 EPS guidance on an as-reported basis is expected in the range of $2.82 to $2.86.  (For a reconciliation of EPS, see note 1.)

The company expects free-cash for fiscal year 2011 in the range of $1.1 billion to $1.3 billion.  The company expects net cash provided by operating activities to be $2 billion to $2.3 billion, and net cash required by investing activities to be approximately $900 million to $1 billion for fiscal year 2011. (For a reconciliation of free cash flow, see note 1.)

Seeds and Genomics Segment Detail


($ in millions)


Net Sales


Gross Profit



Third Quarter


Nine Months


Third Quarter


Nine Months

Seeds and Genomics


2011


2010



2011


2010


2011


2010



2011


2010

Corn Seed and Traits

$

1,123

$

1,020


$

4,134

$

3,836

$

679

$

570


$

2,524

$

2,294

Soybean Seed and Traits


605


549



1,446


1,383


386


292



953


817

Cotton Seed and Traits


487


420



666


513


386


328



502


376

Vegetable Seeds


216


204



628


600


123


112



361


362

All Other Crops Seeds and Traits


216


169



357


309


132


104



176


166

TOTAL Seeds and Genomics

$

2,647

$

2,362


$

7,231

$

6,641

$

1,706

$

1,406


$

4,516

$

4,015




($ in millions)

Earnings (Loss) Before Interest & Taxes (EBIT)





Third Quarter



Nine Months



Seeds and Genomics

2011

2010


2011

2010



EBIT (For a reconciliation of EBIT, see note 1.)

$

880

$

704


$

2,263

$

2,009



Unusual Items Affecting EBIT: Restructuring

$

(1)

$

(68)


$

(15)

$

(130)



The Seeds and Genomics segment consists of the company's global seeds and related traits business.

In total, sales for Monsanto's Seeds and Genomics segment in the third quarter of fiscal 2011 increased 12 percent or $285 million over the prior year period, driven by global unit volume growth and a mix upgrade in the United States.  The company expects to reach the high end of its gross-profit range of $5.1 billion to $5.2 billion for the business on the strength of the double-digit gross profit results year-to-date.

The company expects to achieve the mid-teens millions of U.S. acres it had targeted for both its Genuity® Roundup Ready 2 Yield® soybeans and the Genuity® reduced refuge corn family this year, adding a positive mix improvement across its U.S. soybean and corn portfolios and establishing a foundation for future growth across both crops.  U.S. corn volume growth is complemented by volume growth in Europe and Latin America, where Monsanto has seen volume increases in Argentina and a rebound in planted acres in Brazil.  

The cotton business continues to deliver a strong performance, with an increase in acres and breeding improvements bringing growth.  Monsanto expects to grow volume as the cotton market expands.

The company continues to work towards achieving sales growth and margin expansion in vegetables.

Agricultural Productivity Segment Detail


($ in millions)

Net Sales

Gross Profit (Loss)



Third Quarter


Nine Months

Third Quarter

Nine Months



2011


2010


2011


2010


2011


2010


2011


2010

Agricultural Productivity

$

943

$

600

$

2,318

$

1,908

$

249

$

(19)

$

565

$

210

TOTAL Agricultural Productivity

$

943

$

600

$

2,318

$

1,908

$

249

$

(19)

$

565

$

210




($ in millions)

Earnings (Loss) Before Interest & Taxes (EBIT)






Third Quarter



Nine Months



Agricultural Productivity


2011



2010



2011



2010



EBIT (For a reconciliation of EBIT, see note 1.)

$

76


$

(175)


$

196


$

(228)



Unusual Items Affecting EBIT:















EBIT from Discontinued Operations

$

—


$

—


$

4


$

5




Restructuring

$

—


$

(18)


$

4


$

(54)



The Agricultural Productivity segment consists of the crop protection products and lawn-and-garden herbicide products. The segment saw a strong quarter, with gross profit of $249 million led by the positive response to the repositioning of the glyphosate business and contributions from the lawn-and-garden business, which despite unfavorable weather is set to achieve its second year of above-historical profitability.

The company now expects the segment to deliver gross profit of roughly $700 million for the year, an increase from the previous estimate.

Sales in the third quarter of fiscal 2011 for Monsanto's Agricultural Productivity segment increased 57 percent, with gross profit improvement as well as a function of volume and cost improvements.  

Monsanto announced the staff of the Securities and Exchange Commission is conducting an investigation regarding Monsanto's customer incentive programs relating to its glyphosate products in fiscal years 2009 and 2010, and Monsanto has received a subpoena for documents in connection therewith.  Monsanto is cooperating with the staff's investigation.

Webcast Information

In conjunction with this announcement, Monsanto will hold a conference call at 8:30 a.m. central time (9:30 a.m. eastern time) today. The call will focus on these results and future expectations and may include a discussion of Monsanto's strategic initiatives, product performance and other matters related to the company's business.

Presentation slides and a simultaneous audio webcast of the conference call may be accessed by visiting the company's web site at www.monsanto.com and clicking on "Investor Information" or at http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=122069&eventID=4137207.  Visitors may need to download Windows Media Player™ prior to listening to the webcast. Following the live broadcast, a replay of the webcast will be available on the Monsanto Web site for three weeks.

About Monsanto Company

Monsanto Company is a leading global provider of technology-based solutions and agricultural products that improve farm productivity and food quality. Monsanto remains focused on enabling both small-holder and large-scale farmers to produce more from their land while conserving more of our world's natural resources such as water and energy. To learn more about our business and our commitments, please visit: www.monsanto.com.  Follow our business on Twitter® at www.twitter.com/MonsantoCo, on the company blog, Beyond the Rows® at www.monsantoblog.com, or subscribe to our News Release RSS Feed.

Cautionary Statements Regarding Forward-Looking Information:

Certain statements contained in this release are "forward-looking statements," such as statements concerning the company's anticipated financial results, current and future product performance, regulatory approvals, business and financial plans and other non-historical facts. These statements are based on current expectations and currently available information. However, since these statements are based on factors that involve risks and uncertainties, the company's actual performance and results may differ materially from those described or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, among others: continued competition in seeds, traits and agricultural chemicals; the company's exposure to various contingencies, including those related to intellectual property protection, regulatory compliance and the speed with which approvals are received, and public acceptance of biotechnology products; the success of the company's research and development activities; the outcomes of major lawsuits; developments related to foreign currencies and economies; successful operation of recent acquisitions; fluctuations in commodity prices; compliance with regulations affecting our manufacturing; the accuracy of the company's estimates related to distribution inventory levels; the company's ability to fund its short-term financing needs and to obtain payment for the products that it sells; the effect of weather conditions, natural disasters and accidents on the agriculture business or the company's facilities; and other risks and factors detailed in the company's most recent Form 10-K Report to the SEC. Undue reliance should not be placed on these forward-looking statements, which are current only as of the date of this release. The company disclaims any current intention or obligation to update any forward-looking statements or any of the factors that may affect actual results.

Notes to editors: Genuity and Roundup Ready 2 Yield are trademarks of Monsanto Company and its wholly-owned subsidiaries.

Monsanto Company
Selected Financial Information
(Dollars in millions, except per share amounts)
Unaudited


Statements of Consolidated Operations


Three Months Ended



Nine Months Ended




May 31,



May 31,




2011



2010



2011



2010

Net Sales

$

3,590


$

2,962


$

9,549


$

8,549

Cost of Goods Sold


1,635



1,575



4,468



4,324

Gross Profit


1,955



1,387



5,081



4,225

Operating Expenses:













Selling, general and administrative expenses


591



492



1,543



1,500


Research and development expenses


360



302



983



848


Restructuring charges, net


1



34



9



78

Total Operating Expenses


952



828



2,535



2,426

Income From Operations


1,003



559



2,546



1,799

Interest Expense


35



35



117



115

Interest Income


(17)



(18)



(51)



(43)

Other Expense (Income), Net


15



7



38



(3)

Income from Continuing Operations Before Income Taxes


970



535



2,442



1,730

Income Tax Provision


270



138



704



468

Income from Continuing Operations Including Portion













Attributable to Noncontrolling Interest

$

700


$

397


$

1,738


$

1,262

Discontinued Operations:












Income from Operations of Discontinued Businesses


—



—



4



5

Income Tax Provision


—



—



1



—

Income on Discontinued Operations


—



—



3



5

Net Income

$

700


$

397


$

1,741


$

1,267

Less: Net Income Attributable to Noncontrolling Interest


20



13



38



15

Net Income Attributable to Monsanto Company

$

680


$

384


$

1,703


$

1,252














EBIT (see note 1)

$

956


$

529


$

2,459


$

1,781














Basic Earnings per Share Attributable to Monsanto Company:












Income from Continuing Operations

$

1.27


$

0.71


$

3.17


$

2.29

Income on Discontinued Operations


—



—



—



0.01

Net Income Attributable to Monsanto Company

$

1.27


$

0.71


$

3.17


$

2.30














Diluted Earnings per Share Attributable to Monsanto Company:












Income from Continuing Operations

$

1.26


$

0.70


$

3.13


$

2.26

Income on Discontinued Operations


—



—



0.01



0.01

Net Income Attributable to Monsanto Company

$

1.26


$

0.70


$

3.14


$

2.27














Weighted Average Shares Outstanding:













Basic


535.5



543.2



536.9



544.7


Diluted


541.2



549.9



542.9



552.1


Monsanto Company
Selected Financial Information
(Dollars in millions, except per share amounts)
Unaudited


Condensed Statements of Consolidated Financial Position

As of


As of



May 31, 2011


Aug. 31, 2010

Assets






Current Assets:







Cash and cash equivalents (variable interest entities restricted - 2011: $103)

$

1,074


$

1,485


Short-term investments


250



—


Trade receivables, net (variable interest entities restricted - 2011: $88)


3,579



1,590


Miscellaneous receivables


740



717


Deferred tax assets


384



511


Inventory, net


2,826



2,739


Other current assets


134



80

Total Current Assets


8,987



7,122








Property, Plant and Equipment, Net


4,270



4,227

Goodwill


3,364



3,204

Other Intangible Assets, Net


1,335



1,263

Noncurrent Deferred Tax Assets


1,085



1,014

Long-Term Receivables, Net


474



513

Other Assets


571



524

Total Assets

$

20,086


$

17,867








Liabilities and Shareowners' Equity






Current Liabilities:







Short-term debt, including current portion of long-term debt


216



241


Accounts payable


603



752


Income taxes payable


333



66


Accrued compensation and benefits


396



179


Accrued marketing programs


849



839


Deferred revenues


324



219


Grower production accruals


158



130


Dividends payable


—



151


Customer payable


27



83


Restructuring reserves


48



197


Miscellaneous short-term accruals


764



684

Total Current Liabilities


3,718



3,541








Long-Term Debt


2,027



1,862

Postretirement Liabilities


923



920

Long-Term Deferred Revenue


351



395

Noncurrent Deferred Tax Liabilities


145



137

Long-Term Portion of Environmental and Litigation Reserves


183



188

Other Liabilities


669



681

Monsanto Shareowners' Equity


11,859



10,099

Noncontrolling Interest


211



44

Total Shareowners' Equity


12,070



10,143

Total Liabilities and Shareowners' Equity

$

20,086


$

17,867








Debt to Capital Ratio:


16%



17%


Monsanto Company
Selected Financial Information
(Dollars in millions, except per share amounts)
Unaudited


Statements of Consolidated Cash Flows

Nine Months Ended May 31,





2011



2010

Operating Activities:







Net Income

$

1,741


$

1,267


Adjustments to reconcile cash provided (required) by operating activities:







Items that did not require (provide) cash:








Depreciation and amortization


457



446



Bad-debt expense


(6)



41



Stock-based compensation expense


83



72



Excess tax benefits from stock-based compensation


(24)



(40)



Deferred income taxes


(45)



(98)



Restructuring charges, net


9



78



Equity affiliate income, net


(12)



(21)



Net gain on sales of a business or other assets


(5)



(2)



Other items


46



38


Changes in assets and liabilities that provided (required) cash, net of acquisitions:








Trade receivables, net


(1,759)



(1,648)



Inventory, net


36



78



Deferred revenues


30



(80)



Accounts payable and other accrued liabilities


757



(324)



Restructuring cash payments


(164)



(175)



Pension contributions


(47)



(95)



Net investment hedge settlement


—



(4)



Other items


(153)



(71)

Net Cash Provided (Required) by Operating Activities


944



(538)









Cash Flows Required by Investing Activities:








Purchases of short-term investments


(430)



—



Maturities of short-term investments


180



—



Capital expenditures


(326)



(560)



Acquisitions of businesses, net of cash acquired


(99)



(57)



Purchases of long-term equity securities


—



(14)



Technology and other investments


(51)



(26)



Other investments and property disposal proceeds


19



43

Net Cash Required by Investing Activities


(707)



(614)









Cash Flows Required by Financing Activities:








Net change in financing with less than 90-day maturities


(40)



596



Short-term debt proceeds


59



26



Short-term debt reductions


(33)



(54)



Long-term debt proceeds


300



—



Long-term debt reductions


(192)



(3)



Payments on other financing


(3)



(3)



Debt issuance costs


(3)



—



Treasury stock purchases


(486)



(498)



Stock option exercises


45



50



Excess tax benefits from stock-based compensation


24



40



Tax withholding on restricted stock and restricted stock units


(4)



—



Dividend payments


(452)



(434)



Proceeds from noncontrolling interests


69



—



Dividend payments to noncontrolling interests


(50)



(43)

Net Cash Required by Financing Activities


(766)



(323)

Cash Assumed from Initial Consolidations of Variable Interest Entities


77



—

Effect of Exchange Rate Changes on Cash and Cash Equivalents


41



(6)

Net Decrease in Cash and Cash Equivalents


(411)



(1,481)

Cash and Cash Equivalents at Beginning of Period


1,485



1,956

Cash and Cash Equivalents at End of Period

$

1,074


$

475


Monsanto Company
Selected Financial Information
(Dollars in millions)
Unaudited


1.

EBIT, Ongoing EPS and Free Cash Flow:  The presentations of EBIT, ongoing EPS and free cash flow are not intended to replace net income (loss) attributable to Monsanto Company, cash flows, financial position or comprehensive income (loss), and they are not measures of financial performance as determined in accordance with generally accepted accounting principles (GAAP) in the United States. The following tables reconcile EBIT, ongoing EPS and free cash flow to the respective most directly comparable financial measure calculated in accordance with GAAP.






Reconciliation of EBIT to Net Income (Loss):  EBIT is defined as earnings (loss) before interest and taxes. Earnings (loss) is intended to mean net income (loss) attributable to Monsanto Company as presented in the Statements of Consolidated Operations under GAAP. The following table reconciles EBIT to the most directly comparable financial measure, which is net income (loss) attributable to Monsanto.







Three Months Ended


Nine Months Ended




May 31,


May 31,





2011



2010



2011



2010



EBIT – Seeds and Genomics Segment  

$

880


$

704


$

2,263


$

2,009



EBIT – Agricultural Productivity Segment


76



(175)



196



(228)



EBIT– Total  


956



529



2,459



1,781



Interest Expense, Net


18



17



66



72



Income Tax Provision(A)


258



128



690



457



Net Income Attributable to Monsanto Company 

$

680


$

384


$

1,703


$

1,252





(A)

Includes the income tax provision from continuing operations, the income tax benefit (provision) on noncontrolling interest, and the income tax provision on discontinued operations.






Reconciliation of EPS to Ongoing EPS:  Ongoing EPS is calculated excluding certain after-tax items which Monsanto does not consider part of ongoing operations.







Fiscal Year

Nine Months




2011

Ended




Guidance

May 31, 2011



Diluted Earnings per Share

$2.82-$2.86

$3.14



Restructuring Charges, Net

$0.02

$0.01



Income on Discontinued Operations

—

(0.01)



Diluted Earnings per Share from Ongoing Business

$2.84-$2.88

$3.14



Reconciliation of Free Cash Flow: Free cash flow represents the total of cash flows from operating activities and investing activities, as reflected in the Statements of Consolidated Cash Flows presented in this release. With respect to the fiscal year 2011 free cash flow guidance, Monsanto does not include any estimates or projections of Net Cash Provided (Required) by Financing Activities because in order to prepare any such estimate or projection, Monsanto would need to rely on market factors and conditions that are outside of its control.





Fiscal Year


Nine Months
Ended




2011


May 31,




Guidance


2011


2010



Net Cash Provided (Required) by Operating Activities

$

2,000-2,300

$

944

$

(538)



Net Cash Required by Investing Activities


(900)-(1,000)


(707)


(614)



Free Cash Flow

$

1,100-1,300


237


(1,152)



Net Cash Required by Financing Activities


N/A


(766)


(323)



Cash Assumed from Initial Consolidations of Variable Interest Entities


N/A


77


—



Effect of Exchange Rate Changes on Cash and Cash Equivalents


N/A


41


(6)



Net Decrease in Cash and Cash Equivalents


N/A


(411)


(1,481)



Cash and Cash Equivalents at Beginning of Period


N/A


1,485


1,956



Cash and Cash Equivalents at End of Period


N/A

$

1,074

$

475



Contact

Media:       Kelli Powers  (314-694-4003)


Analysts:  Bryan Hurley (314-694-8148)

SOURCE Monsanto Company

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.